SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-18-000014
Filing Date
2018-01-08
Accepted
2018-01-08 13:30:55
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4158
  Complete submission text file 0001250853-18-000014.txt   5834
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2120 HEMLOCK RD. WEST NORRITON PA 19403
Business Address
Vogt Frederick G (Reporting) CIK: 0001719678 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 18515801